Azulfidine Alternatives Compared
Azulfidine | Vedolizumab | Mesalamine |
|
---|
Azulfidine (sulfasalazine) | Vedolizumab | Mesalamine |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Alopecia, Inflammatory Bowel Disease, Juvenile Rheumatoid Arthritis, Lymphocytic Colitis, Rheumatoid Arthritis, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis -... View more |
Prescription only
Prescribed for Ulcerative Colitis, Crohn's Disease - Maintenance, Crohn's Disease. vedolizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance, Crohn's Disease, Ulcerative Proctitis... View more |
Related suggestions Ulcerative Colitis
|
|||||||||||||||
More about Azulfidine (sulfasalazine) | More about Vedolizumab | More about Mesalamine | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Azulfidine has an average rating of 5.3 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 33% reported a negative effect. |
Vedolizumab has an average rating of 6.1 out of 10 from a total of 172 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 29% reported a negative effect. |
Mesalamine has an average rating of 7.1 out of 10 from a total of 422 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Azulfidine side effects in more detail. |
See also: vedolizumab side effects in more detail. |
See also: mesalamine side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Azulfidine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all mesalamine prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other sulfasalazine brands include: Azulfidine EN-tabs | Entyvio, Entyvio Pen | Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
10 hours |
600 hours |
10 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 258 drugs are known to interact with Azulfidine:
|
A total of 152 drugs are known to interact with vedolizumab:
|
A total of 120 drugs are known to interact with mesalamine:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
June 20, 1950 |
May 20, 2014 |
December 24, 1987 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.